Indication
Japanese encephalitis vaccination
Japanese encephalitis vaccination is an active immunization procedure indicated for the prevention of disease caused by the mosquito-borne Japanese encephalitis virus, a neurotropic flavivirus endemic across parts of Asia and the Western Pacific. Read more about Japanese encephalitis vaccination
4 drugs 3 manufacturers
Drugs that treat it
Common Japanese encephalitis vaccination therapies.
IXIARO (Japanese encephalitis vaccine/PF)
IXIARO (Japanese encephalitis vaccine/PF)
IXIARO (PF) (Japanese encephalitis vaccine/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonJapanese encephalitis vaccination is an active immunization procedure indicated for the prevention of disease caused by the mosquito-borne Japanese encephalitis virus, a neurotropic flavivirus endemic across parts of Asia and the Western Pacific.
The primary target population includes at-risk individuals, such as travelers spending extended periods in endemic or rural areas, persons with outdoor or occupational exposure, and laboratory personnel working with the virus.
Infection primarily targets the central nervous system, where neuroinvasion and intense neuroinflammation can progress from non-specific febrile symptoms to acute encephalopathy, seizures, focal neurological deficits, and coma.
Clinically apparent encephalitis carries high mortality rates and causes permanent neurocognitive or motor sequelae in a large proportion of survivors, underscoring the role of pre-exposure prophylaxis.
- cdc.gov
Japanese encephalitis vaccination is an active immunization procedure indicated for the prevention of disease caused by the mosquito-borne Japanese encephalitis virus, a neurotropic flavivirus endemic across parts of Asia and the Western Pacific The primary target population includes at-risk individuals, such as travelers spending extended periods in endemic or rural areas, persons with outdoor or occupational exposure, and laboratory personnel working with the virus Infection primarily targets ...
- nih.gov
Japanese encephalitis vaccination is an active immunization procedure indicated for the prevention of disease caused by the mosquito-borne Japanese encephalitis virus, a neurotropic flavivirus endemic across parts of Asia and the Western Pacific The primary target population includes at-risk individuals, such as travelers spending extended periods in endemic or rural areas, persons with outdoor or occupational exposure, and laboratory personnel working with the virus Clinically apparent encephal...
- mdpi.com
Japanese encephalitis vaccination is an active immunization procedure indicated for the prevention of disease caused by the mosquito-borne Japanese encephalitis virus, a neurotropic flavivirus endemic across parts of Asia and the Western Pacific Infection primarily targets the central nervous system, where neuroinvasion and intense neuroinflammation can progress from non-specific febrile symptoms to acute encephalopathy, seizures, focal neurological deficits, and coma
- asm.org
Infection primarily targets the central nervous system, where neuroinvasion and intense neuroinflammation can progress from non-specific febrile symptoms to acute encephalopathy, seizures, focal neurological deficits, and coma
- biologists.com
Infection primarily targets the central nervous system, where neuroinvasion and intense neuroinflammation can progress from non-specific febrile symptoms to acute encephalopathy, seizures, focal neurological deficits, and coma
- who.int
Clinically apparent encephalitis carries high mortality rates and causes permanent neurocognitive or motor sequelae in a large proportion of survivors, underscoring the role of pre-exposure prophylaxis
Personalize your experience
Follow Japanese encephalitis vaccination and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.